Head, Lipid Nanoparticle Platform, Takeda Pharmaceuticals
Co-founder, INTREPID
Scientific Consultant, INTREPID
The INTREPID Alliance, Inc was registered as a Delaware non-stock corporation in April 2021, to provide a framework for start-up activities.
The Board, consisting of 7 founding member companies was elected on May 19, 2022, and terms of reference were agreed.
For more information and membership inquiries contact nina@intrepidalliance.com.